MPM leads largest European VC financing of year
UK-based drug development company Oxagen has received almost £32m in a series B round of financing led by MPM Capital in its first European investment.
16 January 2013•1 min read
UK-based drug development company Oxagen has received almost £32m in a series B round of financing led by MPM Capital in its first European investment.
